Burak Uz, Yahya Buyukasik, Hilmi Atay, Engin Kelkitli, Mehmet Turgut, Ozlen Bektas, Eylem Eliacik, Ayşe Isik, Salih Aksu, Hakan Goker, Nilgun Sayinalp, Osman I Ozcebe, Ibrahim C Haznedaroglu
OBJECTIVES: The validity of the three currently used chronic myeloid leukemia (CML) scoring systems (Sokal CML prognostic scoring system, Euro/Hasford CML scoring system, and the EUTOS CML prognostic scoring system) were compared in the CML patients receiving frontline imatinib mesylate. PATIENTS AND METHODS: One hundred and fourty-three chronic phase CML patients (71 males, 72 females) taking imatinib as frontline treatment were included in the study. The median age was 44 (16-82) years...
September 2013: Hematology (Amsterdam, Netherlands)